Alnylam Pharmaceuticals
ALNY
#1123
Rank
NZ$37.79 B
Marketcap
NZ$282.15
Share price
3.61%
Change (1 day)
-63.95%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company